ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 17 of 34 for:    "Diabetic Ketoacidosis"

Fluid Resuscitation for Pediatric Diabetic Ketoacidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01701557
Recruitment Status : Completed
First Posted : October 5, 2012
Last Update Posted : October 5, 2012
Sponsor:
Information provided by (Responsible Party):
University of Colorado, Denver

Brief Summary:
Randomized trial to determine if the volume of fluid administration in pediatric patients with DKA impacts the rate of normalization of serum bicarbonate, pH as well as the length of treatment

Condition or disease Intervention/treatment Phase
Diabetes Other: slow fluid rate Other: fast fluid rate Not Applicable

Detailed Description:
A randomized trial of two initial volumes of IVF and subsequent administration rates. Group I received 10 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.25 times maintenance and Group II received 20 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.5 times maintenance. The specific variables measured included demographics (age, gender, and race/ethnicity) and routine laboratory values (pH, pCO2, plasma glucose, electrolytes, bicarbonate, sodium, chloride, BUN. Length of treatment was defined as a time of the hospital stay after the start of IVF infusion.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Fluid Resuscitation for Pediatric Diabetic Ketoacidosis
Study Start Date : November 2007
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2010

Arm Intervention/treatment
Active Comparator: slow fluid rate
bolus 10 ml/kg of NS followed by 1.25 times maintenance rate
Other: slow fluid rate
10 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.25 times maintenance
Other Name: normal saline

Active Comparator: Fast fluid rate
bolus 20 ml/kg of NS followed by 1.5 times maintenance rate
Other: fast fluid rate
20 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.5 times maintenance
Other Name: normal saline




Primary Outcome Measures :
  1. time to normalization of bicarbonate and pH [ Time Frame: start of treatment until resolution of DKA an expected average of 12 to 24 hours ]
    Laboratory parameters were measured hourly for the first 4 hours, and every 2 to3 hours thereafter until acid-base normalization (pH was above 7.3 or the HCO3 was above 15 mmol/L)


Secondary Outcome Measures :
  1. the length of treatment [ Time Frame: discharge from the hospital, an expected average of 1-2 days ]
    Length of treatment was defined as a time of the hospital stay after the start of IVF infusion



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 1 day to 18 years of age
  • type 1 diabetes
  • presence of DKA, as defined by glucose >250 mg/dl, accumulation of ketone bodies in the blood, and metabolic acidosis (venous pH < 7.30 or serum bicarbonate < 15 mmol/L.)

Exclusion Criteria:

  • requirement for additional fluid resuscitation for hemodynamic instability
  • weight greater than 70 kilograms

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01701557


Locations
United States, Colorado
the Childrens Hospital Colorado
Aurora, Colorado, United States, 80045
Sponsors and Collaborators
University of Colorado, Denver
Investigators
Principal Investigator: Arleta Rewers, MD University of Colorado, Denver

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT01701557     History of Changes
Other Study ID Numbers: 06-0846
First Posted: October 5, 2012    Key Record Dates
Last Update Posted: October 5, 2012
Last Verified: October 2012

Keywords provided by University of Colorado, Denver:
Ketoacidosis Fluids

Additional relevant MeSH terms:
Ketosis
Diabetic Ketoacidosis
Acidosis
Acid-Base Imbalance
Metabolic Diseases
Diabetes Mellitus
Glucose Metabolism Disorders
Diabetes Complications
Endocrine System Diseases